Project
Pharmacology, pharmacogenomics, drug discovery and design, drug therapy [116]
PhD Student
Virgile Andreani
Physicist and computer scientist by training, I develop quantitative population models of antibiotic resistance, which I calibrate using optimal experimental design. I then exploit them to engineer optimal treatment strategies.
Permanent Researcher
Dorian Obino
Pathogenesis of vascular infections
Born and raised in the south of France, I moved to Paris to study at the Magistère Européen de Génétique (Université Paris VII, now Université Paris Cité) where I specialized in immuno-genetics and cell biology. […]
Software
GDSCTools: drug discovery
Thomas Cokelaer
Permanent Researcher
Olivier Sperandio
Chemoinformatics and proteochemometrics
Project
Mechanism of ageing and progeroid diseases
Miria Ricchetti
Project
A synthetic carbohydrate-based conjugate vaccine ready for a clinical trial
Laurence Mulard
Laboratory
Bioorganic chemistry of nucleic acids
Marcel Hollenstein
Project
Pharmacological prevention and treatment of long-term cognitive and behavioral effects of neuroinflammation
Franck Verdonk • Fabrice Chretien
Project
Silence to cure: stabilize chromatin for the management of diseases with inflammatory components
Assistant Professor
Guilherme Dias de Melo
Trypanosomatids Infectious Processes
Guilherme Dias de Melo is veterinarian. He obtained his degree in Veterinary Medicine (december 2010), his MD in Veterinary Sciences (june 2012) and his PhD in Veterinary Sciences (june 2015) at the Sao Paulo […]
Partnerteam
ManRos Therapeutics
Project
ANR Patho-Methylome – The role of lysine methylation in host-pathogen interactions
Jonathan Weitzman
Project
FP7 Anti-Parasitic Drug Discovery in Epigenetics (A-ParaDDisE)
Raymond J. Pierce
Project
FP7 Targeting the Leishmania kinome for the development of novel anti-parasitic strategies (LeishDrug)
Gérald Spaeth
Project